Health
Tocilizumab, Rheumatoid Arthritis Medication, Found to Reduce Severe COVID-19 Deaths – Science Times
Clinical trials in 12 public and private hospitals in India headed by the University of Bristol and Medanta Institute of Education and Research add evidence to…
India, one of the most ethnically diverse countries, conducted the first randomized trials on the use of rheumatoid arthritis medication, Tocilizumab, to reduce death risks in severe COVID-19 cases.
Headed by researchers from the University of Bristol and Medanta Institute of Education and Research, they explained that data gathered from clinical trials add to existing evidence that supports the use of Tocilizumab, an anti-inflammatory drug, in critically ill patients.
Science Behind Tocilizumab…
-
General12 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News21 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News11 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
Noosa News14 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland